激肽释放酶-激肽系统包含多种具有血管活性的多肽分子,这些多肽分子在心脏分布丰富,在心肌梗死(心梗)后可以通过多种途径改善心室重构、缩小心肌梗死面积、减少心肌细胞凋亡、抑制心肌纤维化,从而改善心梗后心功能。已有研究表明,激肽可以通过B2受体增加冠状动脉血流。近年来大量研究提示,激肽及其B1、B2受体可通过多种途径促进心脏血管再生;在增加心肌细胞灌注的同时,激肽可以通过多种途径来减少缺血-再灌注带来的损伤,进一步发挥对心梗后心脏的保护作用。作者对激肽释放酶-激肽系统在心梗后心细胞灌注中的作用作一综述。

[1] BRITOS J,NOLLY H L.Kinin-forming enzyme of rat cardiac tissue.Subcellular distribution and biochemical properties[J].Hypertension,1981,3(6 Pt 2),Ⅱ-42-45.
[2] SHARMA J N,UMA K,YUSOF A P.Left ventricular hypertrophy and its relation to the cardiac kinin-forming system in hypertensive and diabetic rats[J].Int J Cardiol,1998,63(3):229-235.
[3] NOLLY H L,SAED G,SCICLI G,et al.The kallikrein-kinin system in cardiac tissue[J].Agents Actions Suppl,1992,38(Pt 3):62-72.
[4] SHARMA J N.Does kinin mediate the hypotensive action of angiotensin converting enzyme(ACE) inhibitors?[J].Gen Ph-armacol,1990,21:451-457.
[5] SHARMA J N.Involvement of the kinin-forming system in physiopathology of rheumatoid inflammation[J].Agents Acti-ons Suppl,1992,38(Pt 3),343-361.
[6] HILLMEISTER P,PERSSON P B.The Kallikrein-Kinin system[J].Acta Physiol(Oxf),2012,206:215-219.
[7] BERNE R M,GEIGER S R,SPERELAKIS N.Handbook of Physiology[M]//The Heart.Bethesda:American Physiological Society,1979,497-531.
[8] BRAUNWALD E,SOBEL B E.Heart Disease[M].London:W.B.Saunders Co.,1980,1279.
[9] HURST J W,SCHANT R C,SONNENBLICK E H,et al.The Heart[M].5th ed.New York:McGraw-Hill Book Co.,1982,35-71.
[10] 陈灏珠,何梅先,魏盟,等.实用心脏病学[M].4版.上海:上海科学技术出版社,2007:872
[11] MATSUKI T,SHOJI T,YOSHIDA S,et al.Sympathetically induced myocardial ischemia causes the heart to release plasma kinin[J].Cardiovasc Res,1987,21:428-432.
[12] ITO H,HAYASHI I,IZUMI T,et al.Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats[J].Br J Pharmacol,2003,138:225-233.
[13] KOCH M,SPILLMANN F,DENDORFER A,et al.Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallik-rein-1 gene after myocardial infarction[J].Eur J Pharmacol,2006,550:143-148.
[14] ZHU P,ZAUGG C E,SIMPER D,et al.Bradykinin improves p-ostischaemic recovery in the rat heart:role of high energy ph-osphates,nitric oxide,and prostacyclin[J].Cardiovasc Res,1995,29:658-663.
[15] YANG S W,LEE W K,LEE E J,et al.Effect of bradykinin on cultured bovine corneal endothelial cells[J].Ophthalmologica,2001,215:303-308.
[16] EMANUELI C,MADEDDU P.Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases[J].Arch Mal Coeur Vaiss,2004,97:679-687.
[17] AGATA J,CHAO L,CHAO J.Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction[J].Hypertension,2002,40:653-659.
[18] SPILLMANN F,GRAIANI G,Van LINTHOUT S,et al.Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium[J].Regen Med,2006,1:235-254.
[19] MUNK V C,SANCHEZ D E MIGUEL L,et al.Angiotensin Ⅱ induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway[J].Hypertension,2007,49:1178-1185.
[20] EMANUELI C,BONARIA SALIS M,STACCA T,et al.Targeting kinin B(1) receptor for therapeutic neovascularization[J].Circulation,2002,105:360-366.
[21] SILVESTRE J S,BERGAYA S,TAMARAT R,et al.Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway[J].Circ Res,2001,89:678-683.
[22] PARENTI A,MORBIDELLI L,LEDDA F,et al.The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway[J].FASEB J,2001,15:1487-1489.
[23] KNOX A J,CORBETT L,STOCKS J,et al.Human airway smooth muscle cells secrete vascular endothelial growth factor:up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism[J].FASEB J,2001,15:2480-2488.
[24] THURINGER D,MAULON L,FRELIN C.Rapid transactivat-ion of the vascular endothelial growth factor receptor KDR/FIk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells[J].J Biol Chem,2002,277:2028-2032.
[25] EMANUELI C,SALIS M B,Van LINTHOUT S,et al.Akt/pro-tein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer[J].Circulation,2004,110:1638-1644.
[26] YAO Y Y,YIN H,SHEN B,et al.Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3β pathway[J].Cardiovasc Res,2008,80:354-364.
[27] YAO Y,SHENG Z,LI Y,et al.Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis[J].Lab Invest,2013,93(5):577-591.
[28] KRÄNKEL N,KATARE R G,SIRAGUSA M,et al.Role of Kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential[J].Circ Res,2008,103(11):1335-1343.
[29] YAO Y Y,SHENG Z L,LI Y F,et al.Tissue Kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity[J].Hum Gene Ther,2012,23:859-870.
[30] BRAUNWALD E,KLONER R A.Myocardial reperfusion:A double-edged sword?[J].J Clin Invest,1985,76:1713-1719.
[31] GARCIA-DORADO D,PIPER H M.Postconditioning:reperfusion of "reperfusion injury" after hibernation[J].Cardiovasc Res,2006,69:1-3.
[32] 徐俊华,刘志勇,谢鹏.左西孟旦后处理对兔心肌缺血再灌注损伤的保护作用[J].现代医学,2009,37(3):200-204.
[33] 吕磊,孟庆欣,徐军,等.川芎嗪对大鼠心肌再灌注损伤保护机制的实验研究[J].东南大学学报:医学版,2012,31(4):410-414.
[34] 李双凤,王丹,王亚平,等.MPTP参与硫化氢对大鼠心肌缺血再灌注损伤的延迟性保护作用[J].东南大学学报:医学版,2010,29(6):648-651.
[35] BACAKSIZ A,TEKER M E,BUYUKPINARBASILI N,et al.Does pantoprazole protect against reperfusion injury following myocardial ischemia in rats?[J].Eur Rev Med Pharmacol Sci,2013,17(2):269-275.
[36] BULVIK B E,BERENSHTEIN E,MEYRON-HOLTZ E G,et al.Cardiac protection by preconditioning is generated via an iron-signal created by proteasomal degradation of iron proteins[J].PLoS One,2012,7(11):e48947.
[37] LUAN H F,ZHAO Z B,ZHAO Q H,et al.Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway[J].Braz J Med Biol Res,2012,45(10):898-905.
[38] YOSHIDA H,ZHANG J J,CHAO L,et al.Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion[J].Hypertension,2000,35:25-31.
[39] YIN H,CHAO L,CHAO J.Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways[J].J Biol Chem,2005,280:8022-8030.
[40] YIN H,CHAO L,CHAO J.Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion[J].Life Sci,2008,82(3-4):156-165.